Who owns CUE?
Institutional ownership of Cue Biopharma Inc. from Form 13F, Q2 2026
49 institutional managers reported holding Cue Biopharma Inc. (CUE) in Form 13F filings for Q2 2026, with 1,641,351 shares worth $51.8M. The largest reported holder was Bleichroeder LP. Managers that filed both quarters added a net 1,641,294 shares (+2879463.2%). 48 opened new positions and 1 sold out.
- Funds holding
- 49
- Value held
- $51.8M
- New / sold out
- 48 / 1
- Net shares, same filers
- +2879463.2%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of CUE
Share of 13F holdings is each fund's shares as a share of the 1,641,351 CUE shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Bleichroeder LP New+$11.7M
- Driehaus Capital Management LLC New+$9.2M
- Vanguard Capital Management LLC New+$5.1M
- Ikarian Capital, LLC New+$3.3M
- Tetragon Partners GP Ltd New+$3.0M
- Stempoint Capital LP New+$2.1M
- BlackRock, Inc. New+$1.8M
- ADAR1 Capital Management, LLC New+$1.7M
- Lion Point Capital, LP New+$1.7M
- Squadron Capital Management LLC New+$1.6M
Biggest sellers in Q2 2026
- Advisory Services Network, LLC Sold out-$46
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $51.8M and sold $46; 0 added and 0 trimmed.
Schedule 13D and 13G filings on CUE
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-16Cormorant Asset Management, LP SCHEDULE 13G filed by Cue Biopharma Inc.Schedule 13G
- 2026-11-16BALYASNY ASSET MANAGEMENT L.P. SCHEDULE 13G filed by Cue Biopharma Inc.Schedule 13G
- 2026-08-14DRIEHAUS CAPITAL MANAGEMENT LLC SCHEDULE 13G filed by Cue Biopharma Inc.Schedule 13G
Questions about CUE ownership
- Who owns CUE stock?
- 49 institutional investment managers reported CUE positions in their Form 13F filings for Q2 2026, holding 1,641,351 shares worth $51.8M in total. Bleichroeder LP reported the largest position.
- Are funds buying or selling CUE?
- In Q2 2026, 48 managers opened new CUE positions, 0 added, 0 trimmed and 1 sold out. Managers that filed in both quarters added a net 1,641,294 shares.
- How current is this CUE institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to CUE by CUSIP. Options are left out. CUE news and filings · CUE insider trades · Top funds